KERENDIA
BAYER HLTHCARE · FINERENONE
Open FDA's page for this record- Application number
- NDA215341
- Sponsor name
- BAYER HLTHCARE
- Submissions
- Submission type
- SUPPL
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20220901
- Review priority
- STANDARD
- Submission class code
- EFFICACY
- Submission class code description
- Efficacy
- Application docs
- ID
- 71995
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/215341Orig1s001ltr.pdf
- Date
- 20220902
- Type
- Letter
- ID
- 72002
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215341s001lbl.pdf
- Date
- 20220902
- Type
- Label
- Submission type
- SUPPL
- Submission number
- 11
- Submission status
- AP
- Submission status date
- 20260916
- Review priority
- PRIORITY
- Submission class code
- EFFICACY
- Submission class code description
- Efficacy
- Application docs
- ID
- 87213
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/215341Orig1s011ltr.pdf
- Date
- 20260921
- Type
- Letter
- ID
- 87232
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215341s011lbl.pdf
- Date
- 20260922
- Type
- Label
- Submission type
- SUPPL
- Submission number
- 9
- Submission status
- AP
- Submission status date
- 20250711
- Review priority
- PRIORITY
- Submission class code
- EFFICACY
- Submission class code description
- Efficacy
- Application docs
- ID
- 82856
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215341Orig1s009lbl.pdf
- Date
- 20260512
- Type
- Label
- ID
- 82867
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/215341Orig1s009ltr.pdf
- Date
- 20250715
- Type
- Letter
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20210709
- Review priority
- PRIORITY
- Submission class code
- TYPE 1
- Submission class code description
- Type 1 - New Molecular Entity
- Application docs
- ID
- 68045
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215341s000lbl.pdf
- Date
- 20210712
- Type
- Label
- ID
- 68048
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/215341Orig1s000ltr.pdf
- Date
- 20210712
- Type
- Letter
- ID
- 68296
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/215341Orig1s000TOC.html
- Date
- 20210805
- Type
- Review
- Products
- Product number
- 002
- Reference drug
- Yes
- Brand name
- KERENDIA
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Active ingredients
- Name
- FINERENONE
- Strength
- 20MG
- Product number
- 003
- Reference drug
- Yes
- Brand name
- KERENDIA
- Reference standard
- Yes
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Active ingredients
- Name
- FINERENONE
- Strength
- 40MG
- Product number
- 001
- Reference drug
- Yes
- Brand name
- KERENDIA
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Active ingredients
- Name
- FINERENONE
- Strength
- 10MG
- Harmonized identifiers (openFDA)
- Application number
- NDA215341
- Brand name
- KERENDIA
- Generic name
- FINERENONE
- Manufacturer name
- Bayer HealthCare Pharmaceuticals Inc.
- Product NDC
- 50419-540, 50419-541, 50419-542
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- FINERENONE
- RxCUI
- 2562816, 2562822, 2562824, 2562826, 2720069, 2720071
- SPL ID
- 0be3a1c5-0088-43b1-b2f0-1faa1ea87c5b
- SPL set ID
- fc726765-5d5a-4d6e-b037-b847bda9fb7c
- Package NDC
- 50419-540-01, 50419-540-02, 50419-540-70, 50419-540-06, 50419-541-01, 50419-541-02, 50419-541-70, 50419-541-06, 50419-542-01, 50419-542-02, 50419-542-70, 50419-542-06
- Nui
- N0000193970, N0000000139
- Pharm class epc
- Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]
- Pharm class moa
- Mineralocorticoid Receptor Antagonists [MoA]
- UNII
- DE2O63YV8R
